Low Molecular-Weight Heparin Is Better Than Warfarin for Prevention of Recurrent Venous Thromboembolism in Cancer Patients

Clinical Research in Practice: The Journal of Team Hippocrates
doi 10.22237/crp/1493251200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wayne State University Library System

Related search

Economic Analysis of Low-Dose Heparin vs the Low-Molecular-Weight Heparin Enoxaparin for Prevention of Venous Thromboembolism After Colorectal Surgery

Archives of Internal Medicine
1999English

Low-Molecular-Weight-Heparin Versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in High- And Low-Risk Patients With Active Cancer: A Post Hoc Analysis of the CLOT Study

Journal of Thrombosis and Thrombolysis
Cardiovascular MedicineHematologyCardiology
2019English

Rivaroxaban Versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

Outpatient Use of Low Molecular Weight Heparin Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer

Oncologist
Cancer ResearchMedicineOncology
2012English

Prevention of Venous Thromboembolism in Cancer Patients

Egyptian Journal of Hematology and Bone Marrow Transplantation
2015English

Low Dose Aspirin in Combination With Low-Molecular-Weight Heparin Is Better Than Low Dose Aspirin Alone in the Treatment of Pregnant Women With Recurrent Miscarriages

Journal of Evolution of Medical and Dental Sciences
2014English

Prevention of Recurrent Idiopathic Venous Thromboembolism

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients

Clinical Medicine Insights: Blood Disorders
Hematology
2019English

Anticoagulant Effect of Low Molecular Weight Heparin on Central Venous Catheters in Haemodialysis Patients

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy